FRANKFURT--The following is a summary of analysts' forecasts for
Novartis AG (NVS) first-quarter results, based on a poll of eight
analysts conducted by Dow Jones Newswires (figures in million
dollars, EPS in dollar, target price in francs, according to IFRS).
Earnings figures are scheduled to be released April 24.
===
Net sales:
1st Quarter -total -Pharma -Diovan -Gleevec -Lucentis
AVERAGE 14,220 8,009 806 1,128 598
Prev. Year 13,879 7,877 918 1,143 596
+/- in % +2.5 +1.7 -12 -1.3 +0.4
MEDIAN 14,183 8,039 807 1,150 599
Maximum 14,525 8,159 853 1,162 611
Minimum 13,982 7,810 762 1,086 582
Amount 8 5 7 7 6
Bernstein 14,419 8,159 853 1,159 589
Deutsche Bank 14,329 8,039 823 1,154 590
Helvea 14,062 7,810 779 1,090 610
J.P. Morgan 14,266 8,044 816 1,162 611
Kepler Cheuvreux 14,075 -- 800 1,150 --
Morgan Stanley 13,982 -- 807 1,092 582
UBS 14,100 -- -- -- --
Zuercher KB 14,525 7,995 762 1,086 608
Core Core Net
Operating Net attrib. Core
income income profit EPS EPS
AVERAGE 3,653 3,158 3,045 1.25 1.29
Prev. Year 3,651 3,209 2,369 0.97 1.30
+/- in % +0.1 -1.6 +29 +29 -0.5
MEDIAN 3,702 3,199 3,141 1.28 1.30
Maximum 3,792 3,360 3,280 1.34 1.37
Minimum 3,361 2,795 2,543 1.05 1.15
Amount 7 6 5 5 8
Bernstein 3,726 3,211 3,187 -- 1.32
Deutsche Bank 3,792 3,291 2,543 1.05 1.35
Helvea 3,742 -- -- 1.32 1.30
J.P. Morgan 3,658 3,186 3,141 1.28 1.30
Kepler Cheuvreux 3,590 3,104 -- -- 1.27
Morgan Stanley 3,361 2,795 3,072 1.27 1.15
UBS -- -- -- -- 1.29
Zuercher KB 3,702 3,360 3,280 1.34 1.37
Target price Rating
AVERAGE 76.25 positive 3
Prev. Quarter 80.60 neutral 3
+/- in % -5.4 negative 1
MEDIAN 77.50
Maximum 82.00
Minimum 68.00
Amount 4
Deutsche Bank 75.00 Hold
Helvea 82.00 Buy
J.P. Morgan -- Neutral
Kepler Cheuvreux 68.00 Hold
Morgan Stanley -- Underweight
UBS 80.00 Buy
Zuercher KB -- Overweight
===
Year-earlier figures are as restated by the company.
DJG/mus
Subscribe to WSJ: http://online.wsj.com?mod=djnwires